ARCA:IHE
iShares U.S. Pharmaceuticals ETF | |
| $ 99.13 3.19 ( +3.32%) 04:00 PM EST | |
PE Ratio:
24.07
PB Ratio:
3.93
Volume:
114.43K
Dividend Yield %:
1.43
| |
| Last Holding update 2026-05-22 | 56 Stocks (4 new) |
| Value $1.00 Bil | Turnover 15 % |
Registrant: iSHARES TRUST
| |
Year: 2026
GuruFocus Rankings
Financial Strength
6 /10
Profitability Rank
7 /10
GF Value Rank
6 /10
Growth Rank
7 /10
Momentum Rank
6 /10
iShares U.S. Pharmaceuticals ETF Geographic Breakdown
iShares U.S. Pharmaceuticals ETF Performance
Dividend
Log
Bar
Annualized Return %
Total Annual Return %
iShares U.S. Pharmaceuticals ETF Key Statistics
| Name | Value | ||
|---|---|---|---|
| Day's Open ($) | 95.96 | ||
| Day's Range ($) | 95.96 - 99.245 | ||
| Day's Volume | 114,428 | ||
| 52-Week Range ($) | 64.94 - 99.245 | ||
| Beta | 0.5174 | ||
| 3-Year Sharpe Ratio | 0.81 | ||
| 3-Year Sortino Ratio | 1.39 | ||
| Volatility | 16 | ||
| 14-Day RSI | 72.74 | ||
| 14-Day ATR ($) | 1.736911 | ||
| 20-Day SMA ($) | 93.217 |
Fundamental Data
| Name | Value | ||
|---|---|---|---|
| Market Cap (Mil $) | 1,025.996 | ||
| Shares Outstanding (Mil) | 10.35 | ||
| PE Ratio | 24.07 | ||
| PE Ratio (10y Range) | - | ||
| PE Ratio (10y Median) | - | ||
| PB Ratio | 3.93 | ||
| PB Ratio (10y Range) | - | ||
| PB Ratio (10y Median) | - |
Dividend Data
| Name | Value | ||
|---|---|---|---|
| Dividends per Share (TTM) ($) | 1.467 | ||
| Dividend Yield % | 1.43 | ||
| Dividend Yield % (10y Range) | - | ||
| Dividend Yield % (10y Median) | - | ||
| Next Dividend Payment Date | |||
| Dividend Frequency | Quarterly |
IHE iShares U.S. Pharmaceuticals ETF Fundamental Charts
Historical TTM Price-to-Earnings for IHE iShares U.S. Pharmaceuticals ETF
Historical TTM Price-to-Earnings without NRI for IHE iShares U.S. Pharmaceuticals ETF
Historical Price-to-Book Ratio for IHE iShares U.S. Pharmaceuticals ETF
Historical Dividend Yields for IHE iShares U.S. Pharmaceuticals ETF
iShares U.S. Pharmaceuticals ETF Technical Indicators
Moving Average
Momentum
Gurus Latest Trades with ARCA:IHE
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
ARCA:IHE is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
iShares U.S. Pharmaceuticals E... Top Holdings of 2026-03-31
View Full List
| Ticker | | Company | Shares | Value ($1000) | Shares Change % | Weighting % | Trade Impact % | % of Shares outstanding | 3M Change % | YTD Change % | Market Cap $Mil | Industry |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
JNJ | Johnson & Johnson | 942,632 | 230,417.0 | +4.56% | 23.050 | +1.00% | 0.040 | +7.06% | +24.42% | 613,021.9 | Drug Manufacturers | |
LLY | Eli Lilly and Co | 229,087 | 210,707.4 | +22.25% | 21.080 | +3.84% | 0.030 | +34.92% | +12.80% | 1,077,330.6 | Drug Manufacturers | |
MRK | Merck & Co Inc | 394,200 | 47,418.3 | +3.33% | 4.740 | +0.15% | 0.020 | +8.96% | +24.02% | 317,767.6 | Drug Manufacturers | |
PFE | Pfizer Inc | 1,678,022 | 47,118.9 | +16.16% | 4.710 | +0.66% | 0.030 | -10.44% | +0.82% | 138,439.5 | Drug Manufacturers | |
RPRX | Royalty Pharma PLC | 981,152 | 47,065.9 | +13.59% | 4.710 | +0.56% | 0.220 | +20.38% | +47.01% | 24,938.6 | Biotechnology | |
BMY | Bristol-Myers Squibb Co | 763,754 | 46,321.7 | +5.02% | 4.630 | +0.22% | 0.040 | -2.22% | +9.01% | 117,459.9 | Drug Manufacturers | |
ZTS | Zoetis Inc | 382,419 | 45,205.8 | +21.24% | 4.520 | +0.79% | 0.090 | -34.48% | -39.00% | 31,899.1 | Drug Manufacturers | |
VTRS | Viatris Inc | 3,219,194 | 43,491.3 | +21.65% | 4.350 | +0.77% | 0.280 | +23.04% | +33.26% | 19,017.1 | Drug Manufacturers | |
ELAN | Elanco Animal Health Inc | 1,388,731 | 33,232.3 | +21.66% | 3.320 | +0.59% | 0.280 | -0.04% | +8.57% | 12,271.5 | Drug Manufacturers | |
JAZZ | Jazz Pharmaceuticals PLC | 169,838 | 32,107.9 | +21.66% | 3.210 | +0.57% | 0.270 | +21.61% | +35.31% | 14,449.3 | Biotechnology |
iShares U.S. Pharmaceuticals ETF's Historical Top Holdings Breakdowns
iShares U.S. Pharmaceuticals ETF's Top Stock Picks
View Full List
| Ticker | | Company | Date | Action | Impact % | Price Range | Price | Price Change from Avrg% | Comment | Current Shares | Share Change |
|---|---|---|---|---|---|---|---|---|---|---|---|
LLY | Eli Lilly and Co | 2026-03-31 | Add Add | +3.84% | 878.24 ($1013.81) 1108.09 | $1,208.12 | 19.17% | Add 22.25% | 229,087 | 41,692 | |
INDV | Indivior Pharmaceuticals Inc | 2026-03-31 | New Buy New Buy | +1.06% | 28.78 ($33.03) 36.25 | $41.82 | 26.61% | New holding | 348,967 | 348,967 | |
JNJ | Johnson & Johnson | 2026-03-31 | Add Add | +1.00% | 204.31 ($232.92) 248.56 | $254.66 | 9.33% | Add 4.56% | 942,632 | 41,095 | |
ZTS | Zoetis Inc | 2026-03-31 | Add Add | +0.79% | 113.35 ($123.66) 131.1 | $76.09 | -38.47% | Add 21.24% | 382,419 | 67,007 | |
VTRS | Viatris Inc | 2026-03-31 | Add Add | +0.77% | 12.37 ($13.99) 16.13 | $16.33 | 16.73% | Add 21.65% | 3,219,194 | 573,027 | |
PFE | Pfizer Inc | 2026-03-31 | Add Add | +0.66% | 25.15 ($26.62) 28.08 | $24.29 | -8.75% | Add 16.16% | 1,678,022 | 233,465 | |
ELAN | Elanco Animal Health Inc | 2026-03-31 | Add Add | +0.59% | 22.52 ($24.44) 26.84 | $24.57 | 0.53% | Add 21.66% | 1,388,731 | 247,199 | |
JAZZ | Jazz Pharmaceuticals PLC | 2026-03-31 | Add Add | +0.57% | 160.25 ($174.77) 196.83 | $230.02 | 31.61% | Add 21.66% | 169,838 | 30,232 | |
| AVDL Unlock Delisted | Avadel Pharmaceuticals PLC | 2026-03-31 | Sold Out Sold Out | -0.57% | 21.48 ($21.55) 21.69 | $21.64 | 0.42% | Sold Out | 0 | -224,365 | |
RPRX | Royalty Pharma PLC | 2026-03-31 | Add Add | +0.56% | 38.86 ($43.8) 47.97 | $56.26 | 28.45% | Add 13.59% | 981,152 | 117,352 |
iShares U.S. Pharmaceuticals ETF Total Holding History ($B)
iShares U.S. Pharmaceuticals ETF's Asset Allocation
iShares U.S. Pharmaceuticals ETF Past Portfolios
| Portfolio Date | Number of Stocks | New Stocks | Total Value ($Mil) | Q/Q Turnover |
|---|---|---|---|---|
Top Ranked Articles
- 1
iShares U.S. Pharmaceuticals ETF's Hypothetical Growth since 2026-03-31
iShares U.S. Pharmaceuticals ETF's Yearly Returns
This information is only displayed for Gurus who publicly disclose audited performance records; most hedge funds and private investment firms do not publish such data or only provide limited historical performance information.
| Year | Portfolio % | % | Excess Gain % |
|---|
iShares U.S. Pharmaceuticals ETF's Holdings Heat Map
Size field: